1.Conservative treatment of ectopic pregnancy: an analysis of 124 eases
Mengjun ZHAO ; Donghua BI ; Xuecai DONG
Chinese Journal of Primary Medicine and Pharmacy 2008;15(10):1642-1643
Objective To explore a best therapy regimen for conservative treatment of ectopic pregnancy.Methods Total of 124 cases of ectopic pregnancy underwent medicine therapy. They were divided into 4 groups: A group with MTX orly,B group with mifepristone only,C group with MTX and mifepristone comblnation,and D group with combined MTX, mifepristone and Traditional Chinese medicine (TCM). Results The curative rate was 80.65% ,61.29% ,87.10% and 90.32% in group A,group B,group C,and group D. The curative rate of group D is higher than other groups (P<0.05, P<0.01 ). Conclusion Combined MTX, mifepfistone and TCM has better effect on ectopic pregnany and has less side effects.
2.Clinical analysis and CT features of microscopic polyangiitis with lung involvement
Limin JING ; Xuecai DONG ; Hong GAO ; Lin MA
Chinese Journal of Postgraduates of Medicine 2008;31(13):18-20
Objective To investigate the pathologic foundation,clinical characteristics and CT features of microscopic polyangiitis(MPA)with lung involvement.Methods Clinical data of 6 patients of MPA with lung involvement in 2003-2006 were retrospectively analyzed.Results The types of lung imaging manifestations as the followings:(1)Mutiple flaky shadow in both lung in 3 cases.(2)Ground-glass shadow in 1 case.(3)Disseminated interstitial lung involvement in 2 cases.The main respiratory symptom was haemoptysis except cough and expectoration.Renal damaging often occurred besides the lung.Six cases with positive antineutrophil cytoplasmic antibody(ANCA)and 5 cases with positive P-ANCA/MPO-ANCA were found in laboratory examination.Conclusions The CT manifestations of MPA with lung involvement have no characteristic features.Clinical characteristics and laboratory examination can help to understand and diagnose MPA with lung involvement early.
3.Expression and clinical significance of miR-191 in cervical cancer tissues
ZHANG Ying ; MA Ruixia ; DONG Xuecai ; CHEN Caixia
Chinese Journal of Cancer Biotherapy 2020;27(10):1126-1130
[Abstract] Objective: To investigate the expression of miR-191 in cervical cancer tissues and its effect on the patients' prognosis.
Methods: One hundred and seven cervical cancer tissue specimens from patients who underwent surgical treatment and 46 normal
cervical tissue specimens from patients who underwent surgical resection of uterine fibroids (the control group) in Xinxiang Central
Hospital were collected from December 2012 to December 2014. The expression of miR-191 in cancer tissues was detected by qPCR.
All patients were followed up from the first day after surgery, and the follow-up deadline was December 31, 2019. All patients were
followed up for 5 years, with death as the end event. The survival time and 5-year survival rate of the patients were recorded.
Survival analysis was performed using Kaplan-Meier method and the factors affecting survival prognosis were analyzed using Cox
proportional hazard regression model. Results: The expression level of miR-191 in cervical cancer tissues was significantly higher
than that in the tissues from control group (P<0.01). There were significant differences in miR-191 expression among patients with
different high-risk HPV infection status, different pathological grades and FIGO stages, and different lymph node metastasis status
(all P<0.01). The 5-year survival rate of patients in the miR-191 low expression group was significantly higher than those patients in
the high expression group (81.48% vs 33.75%, χ 2
=16.905, P<0.01). Pathological grade, FIGO stage, lymph node metastasis and the
expression of miR-191 were risk factors affecting the prognosis of cervical cancer patients (HR=0.486, 3.065, 2.339 and 2.755, all
P<0.05). Conclusion: miR-191 is highly expressed in cervical cancer tissues, and its expression level increases with the progression of
malignancy. It is expected to become a potential biomarker for early diagnosis and prognosis evaluation of cervical cancer.